Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Not Yet Recruiting

Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

NCT07739485

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1 Antibody in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (PANKU-Breast04)

NCT07729956

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

NCT07730125

Conditions: Breast Diseases, Breast Neoplasms, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sac-TMT for Active TNBC Brain Metastases

NCT07458113

Conditions: Brain Diseases, Brain Neoplasms, Breast Diseases, +11 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Not Yet Recruiting

Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

NCT07723469

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Mayo Rochester, Minnesota, United States

NYU Langone Health New York, United States

Duke Cancer Center Durham, North Carolina, United States

View Trial Details

Not Yet Recruiting

A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden

NCT07721259

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +8 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

NCT07341867

Conditions: Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

NCT07671092

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations: Research Facility Christchurch, New Zealand

View Trial Details

Not Yet Recruiting

Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

NCT07698106

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease

NCT07681297

Conditions: Advanced Solid Tumor Cancer, Breast Cancer, Breast Diseases, +10 more
Locations: National University Cancer Institute, Singapore, National University Health System Singapore

View Trial Details

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms trial results

Related conditions